Mode
Text Size
Log in / Sign up
N/A Completed N=49 Randomized Single-blind Treatment

Smoking Cessation With the Ottawa Model and SmartCard in Out-patient Respirology Clinic Setting

Source: ClinicalTrials.gov NCT01495689 ↗
Enrolled (actual)
49
Serious AEs
0.0%
Results posted
May 2017
Primary outcomePrimary: Biochemically Confirmed (Exhaled CO ≤ 10 Ppm) Self-reported Continuous Abstinence at 26 Weeks. — 26; 23 Participants

Summary

Cigarette smoking is the most harmful and quitting smoking is very difficult. Despite quitting, it is very difficult to stay quit for long term. In Ottawa the investigators are very lucky to have designed and developed the Ottawa Model for Smoking Cessation ("Ottawa Model"). This project is an end result of pain staking research. The Ottawa Model has been implemented very successfully to the hospitalized patients and has shown very promising results of higher quitting rates. Our objective is to modify the Ottawa Model to suit the needs of patients attending out-patient respirology clinics. The investigators aim to apply the modified Ottawa Model along with the SmartCard to the adult smokers who attend the investigators out-patient Respirology clinic at the Ottawa Hospital. The investigators aim to train a nurse in clinical aspects and implementation of the protocols related to the Ottawa Model. The trained nurse will contact the smokers attending the clinic. Those subjects willing to participate in this study will be divided in to two groups. One group of subjects will get counseling and SmartCard on the day of the clinic and follow-up phone calls. The SmartCard is worth $110 toward the purchase of quit smoking medications (i.e. nicotine patch/gum, varenicline, or bupropion). The subjects can re-deem the card at the investigators hospital pharmacy. Those in the control group will be followed-up as the investigators are currently doing i.e. with standard smoking cessation counseling from the clinic physician and the nurse, +/- prescription for smoking cessation aids without access to the study nurse and the extra counseling or SmartCard. The investigators aim to find increased quitting rates in the group getting on-site access to the smoking cessation aids with the Smartcard and counseling. There are no studies implementing the Ottawa Model along with the SmartCard in out-patient respirology setting so far. The Ottawa Model has proven to be very successful in the in-patient subjects. Thus, the investigators believe, the investigators can modify the Ottawa Model and make it fit the out-patient Respirology setting and increase the quitting rates.

Outcome Measures

OutcomeResultp-value
PRIMARY
Biochemically Confirmed (Exhaled CO ≤ 10 Ppm) Self-reported Continuous Abstinence at 26 Weeks.
26; 23 —
PRIMARY
Self-reported Smoking Status
2; 4; 24; 19 —
SECONDARY
Rate of Recruitment and Retention
16; 16; 10; 7 —

Eligibility Criteria

Inclusion Criteria

  • All adult >18 years of age attending Respirology Clinic at the Ottawa General hospital
  • Current smokers (anyone who had smoked any form of tobacco in the 6 months prior to the clinic visit)
  • Willing to set quit dates in next 30 days

Exclusion Criteria

  • Subjects with less than 2 year life expectancy (end stage cancer, end stage lung or heart disease etc) and/or receiving palliative care
  • Not willing to sign consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01495689). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search